Click for best price
HospitalAcquired Disease Testing Market Size, Share 2023
| Market size in 2022 |
US$ 506.5 million
|
Forecast Market size by 2029 |
US$ 711.6 million
|
| Growth Rate |
CAGR of 5.0% |
Number of Pages |
60 Pages |
The global Hospital-Acquired Disease Testing market was valued at US$ 506.5 million in 2022 and is projected to reach US$ 711.6 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Disease Testing. This report contains market size and forecasts of Hospital-Acquired Disease Testing in global, including the following market information:
- Global Hospital-Acquired Disease Testing Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The increasing incidence of hospital acquired infections (HAI) is one of the key factors propelling the global hospital acquired disease testing market. For the prevention of these infections many countries such as the U.S. have issued rules and regulations to be mounted in the hospitals and clinics. For instance, the U.S. has regulated HHS Action Plan to reduce infections auqired in hospitals. These government plans and movements and increasing investments are expected to poise to growth of the global market of hospital acquired disease testing. Furthermore, the rising number of pathogens with drug-resistant abilities is foreseen to help the market expand. Numerous hospitals around the world are facilitating the pathogen detection procedures with improved surveillance culture. To prevent the transmission of diseases, various health organizations are demanding for effective hospital acquired disease testing solutions.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital-Acquired Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-Acquired Disease Testing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Hospital-Acquired Disease Testing Market Segment Percentages, by Type, 2022 (%)
- UTI Testing
- SSI Testing
- Pneumococcal Infections Testing
- Bloodstream Infections Testing
- MRSA Testing
Global Hospital-Acquired Disease Testing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Hospital-Acquired Disease Testing Market Segment Percentages, by Application, 2022 (%)
- Small and Medium Sized Hospitals
- Large Sized Hospitals
Global Hospital-Acquired Disease Testing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Hospital-Acquired Disease Testing Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital-Acquired Disease Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital-Acquired Disease Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Diatherix Laboratories
- Gen-Probe
- Qiagen
- F. Hoffmann-La Roche
- Cepheid
- Life Technologies Corporation
- Meridian Biosciences
- Cantel Medical Corporation
- Nordion
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Hospital-Acquired Disease Testing, market overview.
- Chapter 2: Global Hospital-Acquired Disease Testing market size in revenue.
- Chapter 3: Detailed analysis of Hospital-Acquired Disease Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Hospital-Acquired Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hospital-Acquired Disease Testing Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 506.5 million
|
| Forecast Market size by 2029 |
US$ 711.6 million
|
| Growth Rate |
CAGR of 5.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital-Acquired Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-Acquired Disease Testing Overall Market Size
2.1 Global Hospital-Acquired Disease Testing Market Size: 2022 VS 2032
2.2 Global Hospital-Acquired Disease Testing Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-Acquired Disease Testing Players in Global Market
3.2 Top Global Hospital-Acquired Disease Testing Companies Ranked by Revenue
3.3 Global Hospital-Acquired Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Disease Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hospital-Acquired Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital-Acquired Disease Testing Market Size Markets, 2022 & 2032
4.1.2 UTI Testing
4.1.3 SSI Testing
4.1.4 Pneumococcal Infections Testing
4.1.5 Bloodstream Infections Testing
4.1.6 MRSA Testing
4.2 By Type - Global Hospital-Acquired Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Disease Testing Revenue, 2018-2023
4.2.2 By Type - Global Hospital-Acquired Disease Testing Revenue, 2024-2032
4.2.3 By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Disease Testing Market Size, 2022 & 2032
5.1.2 Small and Medium Sized Hospitals
5.1.3 Large Sized Hospitals
5.2 By Application - Global Hospital-Acquired Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Disease Testing Revenue, 2018-2023
5.2.2 By Application - Global Hospital-Acquired Disease Testing Revenue, 2024-2032
5.2.3 By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Hospital-Acquired Disease Testing Market Size, 2022 & 2032
6.2 By Region - Global Hospital-Acquired Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Disease Testing Revenue, 2018-2023
6.2.2 By Region - Global Hospital-Acquired Disease Testing Revenue, 2024-2032
6.2.3 By Region - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Disease Testing Revenue, 2018-2032
6.3.2 US Hospital-Acquired Disease Testing Market Size, 2018-2032
6.3.3 Canada Hospital-Acquired Disease Testing Market Size, 2018-2032
6.3.4 Mexico Hospital-Acquired Disease Testing Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Disease Testing Revenue, 2018-2032
6.4.2 Germany Hospital-Acquired Disease Testing Market Size, 2018-2032
6.4.3 France Hospital-Acquired Disease Testing Market Size, 2018-2032
6.4.4 U.K. Hospital-Acquired Disease Testing Market Size, 2018-2032
6.4.5 Italy Hospital-Acquired Disease Testing Market Size, 2018-2032
6.4.6 Russia Hospital-Acquired Disease Testing Market Size, 2018-2032
6.4.7 Nordic Countries Hospital-Acquired Disease Testing Market Size, 2018-2032
6.4.8 Benelux Hospital-Acquired Disease Testing Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Disease Testing Revenue, 2018-2032
6.5.2 China Hospital-Acquired Disease Testing Market Size, 2018-2032
6.5.3 Japan Hospital-Acquired Disease Testing Market Size, 2018-2032
6.5.4 South Korea Hospital-Acquired Disease Testing Market Size, 2018-2032
6.5.5 Southeast Asia Hospital-Acquired Disease Testing Market Size, 2018-2032
6.5.6 India Hospital-Acquired Disease Testing Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Disease Testing Revenue, 2018-2032
6.6.2 Brazil Hospital-Acquired Disease Testing Market Size, 2018-2032
6.6.3 Argentina Hospital-Acquired Disease Testing Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, 2018-2032
6.7.2 Turkey Hospital-Acquired Disease Testing Market Size, 2018-2032
6.7.3 Israel Hospital-Acquired Disease Testing Market Size, 2018-2032
6.7.4 Saudi Arabia Hospital-Acquired Disease Testing Market Size, 2018-2032
6.7.5 UAE Hospital-Acquired Disease Testing Market Size, 2018-2032
7 Hospital-Acquired Disease Testing Companies Profiles
7.1 Diatherix Laboratories
7.1.1 Diatherix Laboratories Company Summary
7.1.2 Diatherix Laboratories Business Overview
7.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Major Product Offerings
7.1.4 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.1.5 Diatherix Laboratories Key News & Latest Developments
7.2 Gen-Probe
7.2.1 Gen-Probe Company Summary
7.2.2 Gen-Probe Business Overview
7.2.3 Gen-Probe Hospital-Acquired Disease Testing Major Product Offerings
7.2.4 Gen-Probe Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.2.5 Gen-Probe Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Hospital-Acquired Disease Testing Major Product Offerings
7.3.4 Qiagen Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.3.5 Qiagen Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Major Product Offerings
7.4.4 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Cepheid
7.5.1 Cepheid Company Summary
7.5.2 Cepheid Business Overview
7.5.3 Cepheid Hospital-Acquired Disease Testing Major Product Offerings
7.5.4 Cepheid Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.5.5 Cepheid Key News & Latest Developments
7.6 Life Technologies Corporation
7.6.1 Life Technologies Corporation Company Summary
7.6.2 Life Technologies Corporation Business Overview
7.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Major Product Offerings
7.6.4 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.6.5 Life Technologies Corporation Key News & Latest Developments
7.7 Meridian Biosciences
7.7.1 Meridian Biosciences Company Summary
7.7.2 Meridian Biosciences Business Overview
7.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Major Product Offerings
7.7.4 Meridian Biosciences Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.7.5 Meridian Biosciences Key News & Latest Developments
7.8 Cantel Medical Corporation
7.8.1 Cantel Medical Corporation Company Summary
7.8.2 Cantel Medical Corporation Business Overview
7.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Major Product Offerings
7.8.4 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.8.5 Cantel Medical Corporation Key News & Latest Developments
7.9 Nordion
7.9.1 Nordion Company Summary
7.9.2 Nordion Business Overview
7.9.3 Nordion Hospital-Acquired Disease Testing Major Product Offerings
7.9.4 Nordion Hospital-Acquired Disease Testing Revenue in Global Market (2018-2023)
7.9.5 Nordion Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital-Acquired Disease Testing Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Disease Testing Market Drivers in Global Market
Table 3. Hospital-Acquired Disease Testing Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Disease Testing in Global Market
Table 5. Top Hospital-Acquired Disease Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hospital-Acquired Disease Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hospital-Acquired Disease Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hospital-Acquired Disease Testing Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Disease Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Disease Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Hospital-Acquired Disease Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hospital-Acquired Disease Testing Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2024-2032
Table 30. Diatherix Laboratories Company Summary
Table 31. Diatherix Laboratories Hospital-Acquired Disease Testing Product Offerings
Table 32. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Diatherix Laboratories Key News & Latest Developments
Table 34. Gen-Probe Company Summary
Table 35. Gen-Probe Hospital-Acquired Disease Testing Product Offerings
Table 36. Gen-Probe Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Gen-Probe Key News & Latest Developments
Table 38. Qiagen Company Summary
Table 39. Qiagen Hospital-Acquired Disease Testing Product Offerings
Table 40. Qiagen Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Qiagen Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Company Summary
Table 43. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Offerings
Table 44. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 45. F. Hoffmann-La Roche Key News & Latest Developments
Table 46. Cepheid Company Summary
Table 47. Cepheid Hospital-Acquired Disease Testing Product Offerings
Table 48. Cepheid Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Cepheid Key News & Latest Developments
Table 50. Life Technologies Corporation Company Summary
Table 51. Life Technologies Corporation Hospital-Acquired Disease Testing Product Offerings
Table 52. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Life Technologies Corporation Key News & Latest Developments
Table 54. Meridian Biosciences Company Summary
Table 55. Meridian Biosciences Hospital-Acquired Disease Testing Product Offerings
Table 56. Meridian Biosciences Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Meridian Biosciences Key News & Latest Developments
Table 58. Cantel Medical Corporation Company Summary
Table 59. Cantel Medical Corporation Hospital-Acquired Disease Testing Product Offerings
Table 60. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Cantel Medical Corporation Key News & Latest Developments
Table 62. Nordion Company Summary
Table 63. Nordion Hospital-Acquired Disease Testing Product Offerings
Table 64. Nordion Hospital-Acquired Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Nordion Key News & Latest Developments
List of Figures
Figure 1. Hospital-Acquired Disease Testing Segment by Type in 2022
Figure 2. Hospital-Acquired Disease Testing Segment by Application in 2022
Figure 3. Global Hospital-Acquired Disease Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Disease Testing Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Hospital-Acquired Disease Testing Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Disease Testing Revenue in 2022
Figure 8. By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 9. By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 10. By Type - Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 12. By Application - Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 14. By Region - Global Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 15. By Country - North America Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 16. US Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 20. Germany Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 21. France Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 28. China Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 32. India Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 34. Brazil Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue Market Share, 2018-2032
Figure 37. Turkey Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2018-2032
Figure 41. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gen-Probe Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Qiagen Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cepheid Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Meridian Biosciences Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nordion Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
